Back to Search
IRA GOLDFINE, MD
MD
Endocrinology, Diabetes & Metabolism Physician
NPI: 1508823675Individual
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
G24592(CA)
Endocrinology, Diabetes & Metabolism PhysicianPrimary
Internal Medicine — Endocrinology, Diabetes & Metabolism
Code: 207RE0101X
G24592(CA)
Research & Publications (20)
The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities.
PMID 18199690·Endocr Rev·2008
6-review
Influence of gender on the relationship between insulin sensitivity, adiposity, and plasma lipids in lean nondiabetic subjects.
PMID 19604524·Metabolism·2009
8-other
Genetic variants of the ENPP1/PC-1 gene are associated with hypertriglyceridemia in male subjects.
PMID 19656007·Metab Syndr Relat Disord·2009
8-other
Inhibitory effects of nordihydroguaiaretic acid (NDGA) on the IGF-1 receptor and androgen dependent growth of LAPC-4 prostate cancer cells.
PMID 18491370·Prostate·2008
8-other
A pilot dose-escalation study of the effects of nordihydroguareacetic acid on hormone and prostate specific antigen levels in patients with relapsed prostate cancer.
PMID 18234062·BJU Int·2008
8-other
Technical evaluation of in vivo abdominal fat and IMCL quantification using MRI and MRSI at 3 T.
PMID 17683890·Magn Reson Imaging·2008
8-other
Nordihydroguaiaretic acid (NDGA), an inhibitor of the HER2 and IGF-1 receptor tyrosine kinases, blocks the growth of HER2-overexpressing human breast cancer cells.
PMID 17562544·J Cell Biochem·2008
8-other
Design, synthesis, and structure-activity relationships of novel insulin receptor tyrosine kinase activators.
PMID 18788731·J Med Chem·2008
7-preclinical
Gender differences in the relationship of ENPP1/PC-1 variants to obesity in a Turkish population.
PMID 18719658·Obesity (Silver Spring)·2008
4-observational
Nordihydroguaiaretic acid inhibits insulin-like growth factor signaling, growth, and survival in human neuroblastoma cells.
PMID 17486636·J Cell Biochem·2007
7-preclinical
Diarylureas are small-molecule inhibitors of insulin-like growth factor I receptor signaling and breast cancer cell growth.
PMID 16648580·Mol Cancer Ther·2006
7-preclinical
IGF-binding protein-1 levels are related to insulin-mediated glucose disposal and are a potential serum marker of insulin resistance.
PMID 16801575·Diabetes Care·2006
8-other
Overexpression of the insulin receptor inhibitor PC-1/ENPP1 induces insulin resistance and hyperglycemia.
PMID 16278247·Am J Physiol Endocrinol Metab·2006
7-preclinical
Increased hepatic levels of the insulin receptor inhibitor, PC-1/NPP1, induce insulin resistance and glucose intolerance.
PMID 15677494·Diabetes·2005
7-preclinical
Novel approach to treat insulin resistance, type 2 diabetes, and the metabolic syndrome: simultaneous activation of PPARalpha, PPARgamma, and PPARdelta.
PMID 18220606·Curr Diabetes Rev·2005
6-review
Nordihydroguaiaretic acid (NDGA) inhibits the IGF-1 and c-erbB2/HER2/neu receptors and suppresses growth in breast cancer cells.
PMID 16142439·Breast Cancer Res Treat·2005
7-preclinical
Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes.
PMID 16025115·Nat Genet·2005
8-other
Oral gene therapy: a novel method for the manufacture and delivery of protein drugs.
PMID 15929688·Diabetes Technol Ther·2005
7-preclinical
Analysis of insulin-stimulated insulin receptor activation and glucose transport in cultured skeletal muscle cells from obese subjects.
PMID 15877289·Metabolism·2005
8-other
Structure-based de novo design of ligands using a three-dimensional model of the insulin receptor.
PMID 15006372·Bioorg Med Chem Lett·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 400 PARNASSUS AVE
SAN FRANCISCO, CA 94143 - Phone
- (415) 353-2350
Quick Facts
- NPI
- 1508823675
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile